Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender

Clinical Respiratory Journal

Volumn 7, Issue 1, 2013, Pages 91-100

  Svensson, Gunnar ^a,c   Ewers, Sven Börje ^b   Ohlsson, Ola ^a   Olsson, Håkan ^b,c  

^a CENTRAL HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Gender; NSCLC; Prognostic factor; SCLC; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE;

ADENOCARCINOMA; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SMALL CELL LUNG CARCINOMA; SWEDEN;

EID: 84875667444     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2012.00289.x     Document Type: Article

References (32)

1. Nou E, Stenkvist B, Graffman S. Bronchial carcinoma: 1. A prospective five year study of an unselected carcinoma population in a Swedish county. Scand J Respir Dis Suppl. 1979;104: 43-82.
2. Nou E. The natural five-year course in bronchial carcinoma. Epidemiologic results. Cancer. 1984;53: 2211-16.
3. Huhti E, Sutinen S, Reinlä A, Poukkula A, Saloheimo A. Lung cancer in a defined geographical area: history and histological types. Thorax. 1980;35: 660-7.
4. Malmberg R, Bergman B, Branehög I, Larsson S, Olling S, Wernstedt L. Lung cancer in West Sweden 1976-1985. Acta Oncol. 1996;35: 185-92.
5. Mäkitaro R, Pääkkö P, Huhti E, Bloigu R, Kinnula VL. An epidemiological study of lung cancer: history and histological types in a general population in northern Finland. Eur Respir J. 1999;13: 436-40.
6. Koyi H, Hillerdal G, Brandén E. A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits. Lung Cancer. 2002;36: 9-14.
7. ROC. 2009 Lung cancer in the Uppsala/Örebro region 1995-2008. ROC Uppsala/Örebroregionen;2009-11-05. Available at: http://www.vinkcancer.se/Global/RccUppsalaOrebrolV%C3%A5rdprocesser/lungcancer/rapporter/regrapport_09.pdf (accessed 15 March 2012).
8. Attner B, Lithman T, Noreen D, Olsson H. 2009 Cancer incidence and survival in Southern Sweden 2000-2007. Report by Southern Regional Health Care Committee 2009-06-22. Available at: http://www.skane.se/upload/Webbplatser/Sodra%20regionvardsnamnden/registerstudier/registerstudier_etapp4a_rapport.pdf (accessed 15 November 2009).
9. Skaug K, Eide GE, Gulsvik A. Predictors of long-term survival of lung cancer patients in a Norwegian community. Clin Respir J. 2011;5: 50-8.
10. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe (review). Lung Cancer. 2003;41: 245-58.
11. Ries LAG, Eisner MP. Cancer of the lung. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. NCI, SEER program, NIH Pub. No. 07-6215, Bethesda, MD. SEER Survival Monograph: Cancer Survival among Adults: U.S. SEER Program, 1988-2001, Patient and Tumour Characteristics. 2007: 73-80.
12. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women; age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20561 cases. Ann Oncol. 2002;13: 1087-93.
13. McDuffie HH, Klaassen DJ, Dosman JA. Female-male differences in patients with primary lung cancer. Cancer. 1987;59: 1825-30.
14. Harichand-Herdt S, Ramalingam SS. Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women. Semin Oncol. 2009;36: 572-80.
15. Bremnes RM, Sundstrom S, AasebØ U, Kaasa S, Hatlevoll R, Aamdal S. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer. 2003;39: 303-13.
16. Statistiska Centralbyrån (the Central Bureau of Statistics, Sweden). Population statistics by region, 2009. Available at: http://www.scb.se (accessed 15 November 2009).
17. World Health Organization. Histological Typing of Lung Tumours, 2nd edn. International classification of tumours, No 1. Geneva, World Health Organization, 1981.
18. Mountain CF. A new international staging system for lung cancer. Chest. 1986;89(Suppl. 4): 225-33.
19. Mountain CF. Revisions in the international systems for staging lung cancer. Chest. 1997;111: 1710-17.
20. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep. 1973;4(part 3): 31-42.
21. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5: 649-55.
22. The National Board of Health and Welfare. National health report 2009. Available at: http://www.Socialstyrelsen.se/publikationer2009/2009-126-71 (accessed 20 January 2012).
23. Kiyohan C, Ohno Y. Sex differences in lung cancer susceptibility: a review. Gend Med. 2010;7: 381-401.
24. Barlow L, Westergren K, Holmberg L, Talbäck L. The completeness of the Swedish Cancer Register - a sample survey for year 1998. Acta Oncol. 2009;48: 27-33.
25. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histological type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117: 294-9.
26. Kachroo S, Tong L, Spitz MR, Xing Y, Merriman K, Zhu DK, Fueger J, Amos CI, Etzel CJ. Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care centre. Cancer Detect Prev. 2008;32: 101-8.
27. Koyi H, Hillerdal G, Brandén E. Patient's and doctors' delays in the diagnosis of chest tumours. Lung Cancer. 2002;35: 53-7.
28. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Augustsson T, Ståhle E. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004;59: 45-9.
29. Cerfolio RJ, Bryant AS, Scott E, Sharma M, Robert F, Spencer SA, Garver RJ. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest. 2006;130: 1796-802.
30. Bertino EM, Confer PD, Colonna JE, Ross P, Otterson GA. Pulmonary neuroendocrine/carcinoid tumors: a review article. Cancer. 2009;115: 4434-41.
31. Fu JB, Kau YT, Severson RK, Kalemkerian GP. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest. 2005;127: 768-77.
32. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978;32: 303-13.